Version 5.4
Mus musculus Protein: Tnfsf10
Summary
InnateDB Protein IDBP-627905.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Tnfsf10
Protein Name tumor necrosis factor (ligand) superfamily, member 10
Synonyms A330042I21Rik; AI448571; APO-2L; Ly81; TL2; Trail;
Species Mus musculus
Ensembl Protein ENSMUSP00000133917
InnateDB Gene IDBG-134362 (Tnfsf10)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 3 experimentally validated interaction(s) in this database.
They are also associated with 18 interaction(s) predicted by orthology.
Experimentally validated
Total 3 [view]
Protein-Protein 2 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 18 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005125 cytokine activity
GO:0005164 tumor necrosis factor receptor binding
GO:0005515 protein binding
GO:0032813 tumor necrosis factor receptor superfamily binding
Biological Process
GO:0006955 immune response
Cellular Component
GO:0005615 extracellular space
GO:0016020 membrane
Protein Structure and Domains
PDB ID MGI:107414
InterPro IPR006052 Tumour necrosis factor domain
IPR008983 Tumour necrosis factor-like domain
PFAM PF00229
PRINTS
PIRSF
SMART SM00207
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q9EQS7
UniProt Splice Variant
Entrez Gene 22035
UniGene
RefSeq
MGI ID
MGI Symbol Tnfsf10
OMIM
CCDS
HPRD
IMGT
EMBL AB052771 AC157919
GenPept BAB19680

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca